Published in Scand J Clin Lab Invest on October 01, 1995
Genetics of hereditary disorders of magnesium homeostasis. Pediatr Nephrol (2003) 0.95
Activation of the calcium sensing receptor stimulates gastrin and gastric acid secretion in healthy participants. Osteoporos Int (2008) 0.89
Effect of transdermal magnesium cream on serum and urinary magnesium levels in humans: A pilot study. PLoS One (2017) 0.75
Variability within individuals of plasma ionic magnesium concentrations. BMC Physiol (2002) 0.75
Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance--a population-based twin study. Diabetologia (1999) 3.64
Randomised controlled trial of structured personal care of type 2 diabetes mellitus. BMJ (2001) 3.12
The epidemic of type 2 diabetes is a statistical artefact. Diabetologia (2005) 2.41
Low birth weight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs. Diabetologia (1997) 2.41
Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins. BMJ (1995) 2.40
Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene. Hum Mol Genet (2001) 2.15
Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest (1992) 1.96
Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone. Br J Nutr (2001) 1.84
Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess--possible role in bone homeostasis. Eur J Endocrinol (2001) 1.71
Evaluation of a near-patient test for C-reactive protein used in daily routine in primary healthcare by use of difference plots. Clin Chem (1997) 1.67
Genetic versus environmental aetiology of the metabolic syndrome among male and female twins. Diabetologia (2001) 1.65
Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance. Diabetologia (2010) 1.64
Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: indication of normalization of the bone-remodeling process during highly active antiretroviral therapy. J Clin Endocrinol Metab (1999) 1.61
Impaired insulin-induced site-specific phosphorylation of TBC1 domain family, member 4 (TBC1D4) in skeletal muscle of type 2 diabetes patients is restored by endurance exercise-training. Diabetologia (2010) 1.57
Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase, and glycogen synthase. Evidence for their role in oxidative and nonoxidative glucose metabolism. J Clin Invest (1987) 1.56
Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes (1996) 1.52
The new Danish Twin Register: establishment and analysis of twinning rates. Int J Epidemiol (1995) 1.50
Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia (1991) 1.49
Clinical impact of mild carbohydrate intolerance in pregnancy: a study of 2904 nondiabetic Danish women with risk factors for gestational diabetes mellitus. Am J Obstet Gynecol (2001) 1.47
Does zygosity influence the metabolic profile of twins? A population based cross sectional study. BMJ (1999) 1.46
Celiac disease and risk of fracture in adults--a review. Osteoporos Int (2014) 1.43
Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator: a randomized placebo-controlled study. J Am Coll Cardiol (1991) 1.39
GLUT4 is reduced in slow muscle fibers of type 2 diabetic patients: is insulin resistance in type 2 diabetes a slow, type 1 fiber disease? Diabetes (2001) 1.38
Independent influence of age on basal insulin secretion in nondiabetic humans. European Group for the Study of Insulin Resistance. J Clin Endocrinol Metab (1999) 1.37
Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol (2010) 1.37
Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus. J Clin Invest (1991) 1.36
Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes. Diabetologia (2001) 1.34
Introduction: strategies to set global quality specifications in laboratory medicine. Scand J Clin Lab Invest (1999) 1.34
Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. Diabetes (1999) 1.31
Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin Endocrinol (Oxf) (2004) 1.30
Maternal anthropometric and metabolic factors in the first half of pregnancy and risk of neonatal macrosomia in term pregnancies. A prospective study. Eur J Endocrinol (2005) 1.30
Expression of insulin regulatable glucose transporters in skeletal muscle from type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1990) 1.30
On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion. Diabetologia (1990) 1.26
Impaired cellular insulin binding and insulin sensitivity induced by high-fructose feeding in normal subjects. Am J Clin Nutr (1980) 1.24
Lumbar vertebral body compressive strength evaluated by dual-energy X-ray absorptiometry, quantitative computed tomography, and ashing. Bone (1999) 1.22
Decreased activation of skeletal muscle glycogen synthase by mixed-meal ingestion in NIDDM. Diabetes (1988) 1.21
Age-dependent impact of zygosity and birth weight on insulin secretion and insulin action in twins. Diabetologia (2002) 1.19
Proposed quality specifications for the imprecision and inaccuracy of analytical systems for clinical chemistry. Eur J Clin Chem Clin Biochem (1992) 1.18
Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group. Diabetologia (1996) 1.17
Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. J Clin Invest (1995) 1.17
A cellular model system of differentiated human myotubes. APMIS (2001) 1.15
Classification of newly diagnosed diabetic patients as insulin-requiring or non-insulin-requiring based on clinical and biochemical variables. Diabetes Care (1989) 1.13
Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study. Diabetologia (2011) 1.13
Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scand J Prim Health Care (2000) 1.12
Localization of a gene for autosomal dominant osteopetrosis (Albers-Schönberg disease) to chromosome 1p21. Am J Hum Genet (1997) 1.11
No association between birth weight and Type 1 diabetes mellitus--a twin-control study. Diabet Med (2000) 1.11
Effect of physical training on mitochondrial respiration and reactive oxygen species release in skeletal muscle in patients with obesity and type 2 diabetes. Diabetologia (2010) 1.11
Osteoclast activity and subtypes as a function of physiology and pathology--implications for future treatments of osteoporosis. Endocr Rev (2010) 1.10
Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol. Diabetologia (2005) 1.09
Rosiglitazone RECORD study: glucose control outcomes at 18 months. Diabet Med (2007) 1.08
Maternal and perinatal outcomes in 143 Danish women with gestational diabetes mellitus and 143 controls with a similar risk profile. Diabet Med (2000) 1.08
Heterogeneity of autosomal dominant osteopetrosis. Radiology (1987) 1.08
Prevalence of surreptitious laxative abuse in patients with diarrhoea of uncertain origin: a cost benefit analysis of a screening procedure. Gut (1989) 1.07
Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population. J Intern Med (2011) 1.07
No associations between OPG gene polymorphisms or serum levels and measures of osteoporosis in elderly Australian women. Bone (2006) 1.07
Protein C activation during the initial phase of experimental acute pancreatitis in the rabbit. Dig Surg (1999) 1.06
Advances in osteoclast biology resulting from the study of osteopetrotic mutations. Hum Genet (2008) 1.06
Changes in patient weight and the impact of antidiabetic therapy during the first 5 years after diagnosis of diabetes mellitus. Diabetologia (2006) 1.06
The pathogenic role of an insulin-receptor defect in diabetes mellitus of the obese. Diabetes (1978) 1.05
Effects of insulin on kidney function and sodium excretion in healthy subjects. Diabetologia (1989) 1.05
Need for revisiting the concept of reference values. Clin Chem Lab Med (2000) 1.04
Insulin receptor binding and receptor-mediated insulin degradation in human adipocytes. Diabetologia (1981) 1.04
Correlations between insulin sensitivity and bone mineral density in non-diabetic men. Diabet Med (2000) 1.03
Assessment of hepatic insulin action in obese type 2 diabetic patients. Diabetes (2001) 1.03
A reduced number of insulin receptors in patients with Prader-Willi syndrome. Acta Endocrinol (Copenh) (1983) 1.03
Prevalence and mortality of acute myocardial infarction in patients with diabetes. Diabetes Care (1985) 1.03
Effects of insulin on glucose turnover rates in vivo: isotope dilution versus constant specific activity technique. Metabolism (1996) 1.03
No evidence of a higher 10 year period prevalence of diabetes among 77,885 twins compared with 215,264 singletons from the Danish birth cohorts 1910-1989. Diabetologia (2011) 1.02
Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study. J Bone Miner Res (2003) 1.02
Increased insulin receptors after exercise in patients with insulin-dependent diabetes mellitus. N Engl J Med (1980) 1.01
Insulin analogues and severe hypoglycaemia in type 1 diabetes. Diabetes Res Clin Pract (2011) 1.01
Direct evidence of fiber type-dependent GLUT-4 expression in human skeletal muscle. Am J Physiol Endocrinol Metab (2000) 1.01
Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women - results of the Danish Osteoporosis Prevention Study. Maturitas (2000) 1.00
Transcriptional profiling of myotubes from patients with type 2 diabetes: no evidence for a primary defect in oxidative phosphorylation genes. Diabetologia (2008) 1.00
Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM. Diabetologia (1995) 1.00
Improved in vivo insulin effect during continuous subcutaneous insulin infusion in patients with IDDM. Diabetes (1984) 0.99
Osteopetrosis. A genetic and epidemiological study. Clin Genet (1987) 0.98
Beta cell function after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol (2010) 0.98
Serum immunoglobulin M, G, and A concentration levels in Turner's syndrome compared with normal women and men. Hum Genet (1976) 0.98
Decreased binding of insulin to its receptor in patients with congenital generalized lipodystrophy. N Engl J Med (1977) 0.98
Human ATP synthase beta is phosphorylated at multiple sites and shows abnormal phosphorylation at specific sites in insulin-resistant muscle. Diabetologia (2009) 0.98
Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism. J Clin Invest (1994) 0.97
Overdosage of antidepressants: clinical and pharmacokinetic aspects. Eur J Clin Pharmacol (1982) 0.97
Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia (1992) 0.97
Age- and gender-related differences in vertebral bone mass, density, and strength. J Bone Miner Res (1999) 0.97
Proliferation conditions for human satellite cells. The fractional content of satellite cells. APMIS (2001) 0.96
The antiviral 2',5'-oligoadenylate synthetase is persistently activated in type 1 diabetes. Clin Immunol (2000) 0.96
Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from NIDDM patients compared with control subjects. Diabetologia (1996) 0.96
Variation in absorption of NPH insulin due to intramuscular injection. Diabetes Care (1990) 0.96
Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy. Thromb Res (1996) 0.96
Intramuscular versus subcutaneous injection of unmodified insulin: consequences for blood glucose control in patients with type 1 diabetes mellitus. Diabet Med (1990) 0.95
Desirable standards for laboratory tests if they are to fulfill medical needs. Clin Chem (1993) 0.95
Cytokines and T-lymphocyte subsets in healthy post-menopausal women: estrogen retards bone loss without affecting the release of IL-1 or IL-1ra. Bone (1997) 0.94